Solid thyroid nodule: Contrast-enhanced ultrasound and immunohistochemistry

Chinese Journal of Medical Imaging Technology

Volumn 27, Issue 9, 2011, Pages 1783-1787

  Zhang, Bo ^a   Jiang, Yu Xin ^a   Dai, Qing ^a   Cui, Quan Cai ^a   Zhang, Qing ^a   Li, Wen Bo ^a   Yang, Meng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Immunohistochemistry; Neovascularization, pathologic; Thyroid nodule; Ultrasonography, interventional

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; PARAFFIN; VASCULOTROPIN;

ARTICLE; CONTRAST ENHANCEMENT; GOITER; HASHIMOTO DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SOLID THYROID NODULE; THYROID ADENOMA; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA;

EID: 84860596911     PISSN: 10033289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Davies L, Welch H G. Increasing incidence of thyroid cancer in the United States 1973-2002. JAMA, 2006, 295(18): 2164-2167.
2. Frates M C, Benson C B, Charboneau J W, et al. Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement. Radiology, 2005, 237(3): 794-800.
3. Sipos J A. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid, 2009, 19(12): 1365-1372.
4. Zhang B, Jiang Y X, Liu J B, et al. Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules. Thyroid, 2010, 20(1): 51-57.
5. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis a new significant and independent prognostic factor in early stage breast carcinoma. Nat Cancer Inst, 1992, 84(24): 1875-1887.
6. Hao X P, Willis J E, Pretlow T G, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res, 2000, 60(1): 18-20.
7. Uenishi T, Kubo S, Yamamoto T, et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci, 2003, 94(10): 851-857.
8. Beeley M F, Mclaren K M. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology, 2002, 41(3): 236-243.
9. Averkiou M, Powers J, Skyba D, et al. Ultrasound contrast imaging research. Ultrasound Q, 2003, 19(1): 27-37.
10. 2010, 26(5): 844-847.
11. Rapheal S L, Mckeown-Eyssen G, Asa S L. High molecular weight cytokeratin and cytokeratin 19 in the diagnosis of thyroid tumor. Mod Pathol, 1994, 7(3): 295-300.